Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schneeweiss

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|December 15, 2015
Improving therapeutic effectiveness and safety through big healthcare dataS Schneeweiss
International Journal of Technology Assessment in Health Care|October 12, 2000
Sensitivity analysis of the diagnostic value of endoscopies in cross-sectional studies in the absence of a gold standardS Schneeweiss
Clinical Pharmacology and Therapeutics|June 8, 2007
Developments in post-marketing comparative effectiveness researchS Schneeweiss
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2003
Frequency and predictors of drug therapy interruptions after hospital discharge under physician drug budgets in GermanyK Taxis, S Schneeweiss
Deutsche Medizinische Wochenschrift (1946)|August 22, 2001
[Provider profiling: needs, methodologic requirements and means to increase acceptance]S Schneeweiss, O Sangha
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 20, 2001
[An update of the German version of AEP (Appropriateness Evaluation Protocol): metric properties and practical experiences]S Schneeweiss, O Sangha
Epidemiology (Cambridge, Mass.)|January 4, 2001
Causation of bias: the episcopeM Maclure, S Schneeweiss
International Journal of Epidemiology|October 18, 2000
Use of comorbidity scores for control of confounding in studies using administrative databasesS Schneeweiss, M Maclure
Clinical Pharmacology and Therapeutics|February 27, 2016
Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugsK J Lin, S Schneeweiss
Pharmacoepidemiology and Drug Safety|April 10, 2004
Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissionsN Muehlberger, S Schneeweiss, J Hasford
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|December 15, 2015
Improving therapeutic effectiveness and safety through big healthcare dataS Schneeweiss
International Journal of Technology Assessment in Health Care|October 12, 2000
Sensitivity analysis of the diagnostic value of endoscopies in cross-sectional studies in the absence of a gold standardS Schneeweiss
Clinical Pharmacology and Therapeutics|June 8, 2007
Developments in post-marketing comparative effectiveness researchS Schneeweiss
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2003
Frequency and predictors of drug therapy interruptions after hospital discharge under physician drug budgets in GermanyK Taxis, S Schneeweiss
Deutsche Medizinische Wochenschrift (1946)|August 22, 2001
[Provider profiling: needs, methodologic requirements and means to increase acceptance]S Schneeweiss, O Sangha
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 20, 2001
[An update of the German version of AEP (Appropriateness Evaluation Protocol): metric properties and practical experiences]S Schneeweiss, O Sangha
Epidemiology (Cambridge, Mass.)|January 4, 2001
Causation of bias: the episcopeM Maclure, S Schneeweiss
International Journal of Epidemiology|October 18, 2000
Use of comorbidity scores for control of confounding in studies using administrative databasesS Schneeweiss, M Maclure
Clinical Pharmacology and Therapeutics|February 27, 2016
Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugsK J Lin, S Schneeweiss
Pharmacoepidemiology and Drug Safety|April 10, 2004
Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissionsN Muehlberger, S Schneeweiss, J Hasford
Pageof 6